1. Home
  2. CLMB vs LXEO Comparison

CLMB vs LXEO Comparison

Compare CLMB & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CLMB

Climb Global Solutions Inc.

HOLD

Current Price

$20.74

Market Cap

387.6M

Sector

Technology

ML Signal

HOLD

Logo Lexeo Therapeutics Inc.

LXEO

Lexeo Therapeutics Inc.

HOLD

Current Price

$5.26

Market Cap

369.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLMB
LXEO
Founded
1982
2017
Country
United States
United States
Employees
N/A
59
Industry
Retail: Computer Software & Peripheral Equipment
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
387.6M
369.8M
IPO Year
1996
2023

Fundamental Metrics

Financial Performance
Metric
CLMB
LXEO
Price
$20.74
$5.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
9
Target Price
$80.00
$18.44
AVG Volume (30 Days)
186.8K
714.3K
Earning Date
04-29-2026
05-06-2026
Dividend Yield
0.60%
N/A
EPS Growth
14.29
39.81
EPS
0.18
N/A
Revenue
$652,517,000.00
$654,000.00
Revenue This Year
$7.82
N/A
Revenue Next Year
$5.83
N/A
P/E Ratio
$113.67
N/A
Revenue Growth
40.14
N/A
52 Week Low
$15.25
$2.51
52 Week High
$145.00
$10.99

Technical Indicators

Market Signals
Indicator
CLMB
LXEO
Relative Strength Index (RSI) 36.37 43.99
Support Level $18.97 $4.95
Resistance Level $23.60 $6.26
Average True Range (ATR) 1.07 0.43
MACD 1.24 -0.07
Stochastic Oscillator 92.10 41.35

Price Performance

Historical Comparison
CLMB
LXEO

About CLMB Climb Global Solutions Inc.

Climb Global Solutions Inc is a cloud-based, value-added IT distribution and solutions company specializing in emerging technologies. It operates across the USA, Canada, United Kingdom, and Europe through multiple business units, including Climb Channel Solutions, Sigma, Grey Matter, Interwork, and TechXtend. The company is organized into two reportable operating segments. The Distribution segment distributes technical software to corporate resellers, value-added resellers (VARs), consultants, and systems integrators under the name Climb Channel Solutions. The Solutions segment is a cloud solutions provider and value-added reseller of software, hardware, and services to customers under the name Grey Matter.

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.

Share on Social Networks: